Closing Bell: Hls Therapeutics Inc up on Friday (HLS)

In trading today, Hls Therapeutics Inc shares closed at $3.35 after opening the day at $3.22. Intraday prices ranged from $3.22 to $3.35.

Share prices raised 6.69% from the previous day's close of $3.14.

Today across North America, the TSX Composite closed 0.91% at 22814.81, the S&P 500 closed -0.51% at 5399.22, the Dow Jones Industrial Average closed 0.20% at 39935.07 and the Nasdaq Composite closed -0.93% at 17181.72.

Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.

Trading volume was 1,500 on 8 total trades, while having an average volume of 97,484 in the last five days.

The TSX market on the whole today saw 3,857 price advancers against 1,325 declines and 128 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $6.30 (August 01,2023) and low as $3.07 (July 24,2024). Moreover, the shares have shrunken -46.83 percent in the last 52 weeks, while they have dipped -15.19% year-to-date.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $99.90 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Based on 5.00 analysts, Hls Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. Currently, there are 3 buy ratings and 2 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..